Literature DB >> 17050587

Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.

C A Davies1, M Jeziorska, A J Freemont, A L Herrick.   

Abstract

OBJECTIVES: Our aim was to evaluate (i) whether the bone matrix proteins osteonectin and matrix gamma-carboxyglutamic acid protein (MGP) are up-regulated in skin biopsies from patients with systemic sclerosis (SSc) and (ii) whether there is differential expression between patients with and without dermal calcinosis, a distressing and debilitating complication of SSc.
METHODS: Skin punch biopsies were taken from the forearms of 38 SSc patients with the limited cutaneous subtype of SSc [17 without calcinosis (lcSSc) and 21 with calcinosis (lcSScCal)] and from 11 healthy control subjects. Immunohistochemistry was performed with antibodies to osteonectin and MGP. Staining was assessed semiquantitatively in the microvascular endothelium and in dermal fibroblasts. The Kruskal-Wallis one-way ANOVA was used to compare the data between patient groups.
RESULTS: Both lcSSc and lcSScCal groups showed a statistically significant increase in the percentage of microvessels with osteonectin-positive endothelial cells (EC) (especially the lcSScCal group), whereas lcSScCal alone showed an increase in the percentage of microvessels with MGP-positive EC when compared with controls. In both SSc groups, the percentage of osteonectin and MGP-stained fibroblasts was increased in the reticular dermis (for osteonectin this was more marked in the lcSScCal group). In the papillary dermis, the percentage of osteonectin-stained fibroblasts was increased in both SSc groups but the lcSScCal group alone had a higher percentage of MGP-stained fibroblasts.
CONCLUSIONS: When compared with controls, protein expression of osteonectin and MGP was greater in SSc patients generally, and osteonectin expression was significantly higher in EC and fibroblasts of the lcSScCal patients than the lcSSc patients without calcinosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050587     DOI: 10.1093/rheumatology/kei277

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.

Authors:  Francesco Del Galdo; M Alexander Shaw; Sergio A Jimenez
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes.

Authors:  Qiaoli Li; Dorothy K Grange; Nicole L Armstrong; Alison J Whelan; Maria Y Hurley; Mark A Rishavy; Kevin W Hallgren; Kathleen L Berkner; Leon J Schurgers; Qiujie Jiang; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2008-09-18       Impact factor: 8.551

3.  Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Authors:  Murray Baron; Janet Pope; David Robinson; Niall Jones; Nader Khalidi; Peter Docherty; Elzbieta Kaminska; Ariel Masetto; Evelyn Sutton; Jean-Pierre Mathieu; Sophie Ligier; Tamara Grodzicky; Sharon LeClercq; Carter Thorne; Geneviève Gyger; Douglas Smith; Paul R Fortin; Maggie Larché; Maysan Abu-Hakima; Tatiana S Rodriguez-Reyna; Antonio R Cabral-Castaneda; Marvin J Fritzler; Mianbo Wang; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2016-09-04       Impact factor: 7.580

4.  Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis.

Authors:  María Pilar Cruz-Domínguez; Grettel García-Collinot; Miguel A Saavedra; Gabriela Medina; Rosa Angélica Carranza-Muleiro; Olga Lidia Vera-Lastra; Luis J Jara
Journal:  Clin Rheumatol       Date:  2016-10-07       Impact factor: 2.980

Review 5.  Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Authors:  Antonia Valenzuela; Lorinda Chung
Journal:  J Scleroderma Relat Disord       Date:  2021-10-28

6.  Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.

Authors:  Jiu-Cun Wang; Syeling Lai; Xinjian Guo; Xuefeng Zhang; Benoit de Crombrugghe; Sonali Sonnylal; Frank C Arnett; Xiaodong Zhou
Journal:  Arthritis Res Ther       Date:  2010-04-01       Impact factor: 5.156

7.  Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications.

Authors:  Carla S B Viegas; Sofia Cavaco; Pedro L Neves; Ana Ferreira; Alexandre João; Matthew K Williamson; Paul A Price; M Leonor Cancela; Dina C Simes
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

8.  Juvenile dermatomyositis calcifications selectively displayed markers of bone formation.

Authors:  Annette L Urganus; Yong-Dong Zhao; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2009-04-15

9.  The Immunohistochemical Patterns of Calcification-related Molecules in the Epidermis and Dermis of the Zebrafish (Danio rerio).

Authors:  Yeon Ju Hong; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

10.  Fibroblast involvement in soft connective tissue calcification.

Authors:  Ivonne Ronchetti; Federica Boraldi; Giulia Annovi; Paolo Cianciulli; Daniela Quaglino
Journal:  Front Genet       Date:  2013-03-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.